GIEPIA (http://gepia2.cancer-pku.cn/, accessed on 6 May 2025) [15] and UALCAN (https://ualcan.path.uab.edu/, accessed on 5 March 2025) [16] analysis platforms showed that the abundance of mRNA and protein associated with NUP37, PGM2L1, and ENO1 were higher in PAAD than in normal pancreatic tissue, and upregulated expression of individual genes predicted worse clinical outcomes (Supplementary Figure S5A–C). The gene discussed is ENO1; the disease is pancreatic adenocarcinoma.